NANOGP8: Evolution of a human-specific retro-oncogene

G3: Genes, Genomes, Genetics

Volumn 2, Issue 11, 2012, Pages 1447-1457

  Fairbanks, Daniel J ^a,b   Fairbanks, Aaron D ^a   Heath Ogden, T ^a   Parker, Glendon J ^a   Maughan, Peter J ^b  

^a UTAH VALLEY UNIVERSITY   (United States)

^b BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

Cancer; Human diversity; Pseudogene evolution; Retroelement; SVA element

Indexed keywords

HOMEODOMAIN PROTEIN; NANOG PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ALLELE; ALU SEQUENCE; ANIMAL; ARTICLE; GENE DELETION; GENETIC POLYMORPHISM; GENETICS; HOMO NEANDERTHALENSIS; HUMAN; HUMAN GENOME; LONG INTERSPERSED REPEAT; MOLECULAR EVOLUTION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; ONCOGENE; PSEUDOGENE; RETROPOSON;

3' UNTRANSLATED REGIONS; ALLELES; ALU ELEMENTS; ANIMALS; BASE SEQUENCE; EVOLUTION, MOLECULAR; GENE DELETION; GENOME, HUMAN; HOMEODOMAIN PROTEINS; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MOLECULAR SEQUENCE DATA; NEANDERTHALS; ONCOGENES; POLYMORPHISM, GENETIC; PSEUDOGENES; RETROELEMENTS;

EID: 84883169900     PISSN: None     EISSN: 21601836     Source Type: Journal    
DOI: 10.1534/g3.112.004366     Document Type: Article

References (46)

1. Ambady, S., C. Malcuit, O. Kashpur, D. Kole, W. F. Holmes et al., 2010 Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells. Int. J. Dev. Biol. 54: 1743- 1754.
2. Beniashvili, D. S., 1989 An overview of world literature on spontaneous tumors in nonhuman primates. J. Med. Primatol. 18: 423-437.
3. Booth, H. A. F., and P. W. H. Holland, 2004 Eleven daughters of NANOG. Genomics 84: 229-238.
4. Chambers, I., D. Colby, M. Robertson, J. Nichols, S. Lee et al., 2003 Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643-655.
5. Chambers, I., J. Silva, D. Colby, J. Nichols, B. Nijmeijer et al., 2007 Nanog safeguards pluripotency and mediates germline development. Nature 450: 1230-1234.
6. Chimpanzee Sequencing and Analysis Consortium, 2005 Initial sequence of the chimpanzee genome and comparison with the human genome. Nature 437: 69-87.
7. Cohen, C. J., W. M. Lock, and D. L. Mager, 2009 Endogenous retroviral LTRs as promoters for human genes: a critical assessment. Gene 448: 105-114.
8. Dunn, C. A., M. T. Romanish, L. E. Gutierrez, L. N. van de Lagemaat, and D. L. Mager, 2006 Transcription of two human genes from a bidirectional endogenous retrovirus promoter. Gene 366: 335-342.
9. Eberle, I., B. Pless, M. Braun, T. Dingermann, and R. Marschalek, 2010 Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cells. Nucleic Acids Res. 38: 5384-5395.
10. Fairbanks, D. J., and P. J. Maughan, 2006 Evolution of the NANOG pseudogene family in the human and chimpanzee genomes. BMC Evol. Biol. 6: 12.
11. Fuchs, N. V., M. Kraft, C. Tondera, K. M. Hanschmann, J. Löwer et al., 2011 Expression of the human endogenous retrovirus (HERV) group HML-2/HERV-K does not depend on canonical promoter elements but is regulated by transcription factors Sp1 and Sp3. J. Virol. 85: 3436-3448.
12. Gogvadze, E., E. Stukacheva, A. Buzdin, and E. Sverdlov, 2009 Humanspecific modulation of transcriptional activity provided by endogenous retroviral insertions. J. Virol. 83: 6098-6105.
13. Green, R. E., A. S. Malaspinas, J. Krause, A. W. Briggs, P. L. F. Johnson et al., 2008 A complete Neandertal mitochondrial genome sequence determined by high-throughput sequencing. Cell 134: 416- 426.
14. Green, R. E., J. Krause, A. W. Briggs, T. Maricic, U. Stenzel et al., 2010 A draft sequence of the Neanderthal genome. Science 328: 710-722.
15. Heinemeyer, T., E. Wingender, I. Reuter, H. Hermjakob, A. E. Kel et al., 1998 Databases on transcriptional regulation: TRANSDAC, TRRD, and COMPEL. Nucleic Acids Res. 26: 364-370.
16. Ibrahim, E. E., R. Babaei-Jadidi, A. Saadeddin, B. Spencer-Deen, S. Hossaini et al., 2012 Embryonic NANOG activity defines colorectal cancer stem cells and modulated through AP1- and TCF-dependent mechanisms. Stem Cells 30: 2076-2087.
17. International Human Genome Sequencing Consortium, 2001 Initial sequencing and analysis of the human genome. Nature 409: 860-921.
18. Ishiguro, T., A. Sato, H. Ohata, H. Sakai, H. Nakagama et al., 2012 Differential expression of Nanog1 and Nanogp8 in colon cancer cells. Biochem. Biophys. Res. Commun. 418: 199-204.
19. Jeter, C. R., M. Badeaux, G. Choy, D. Chandra, L. Patrawala et al., 2009 Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 27: 993-1005.
20. Jeter, C. R., B. Liu, X. Liu, X. Chen, C. Liu et al., 2011 NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene 30: 3833-3845.
21. Keightly, P. D., 2012 Rates and fitness consequences of new mutations in humans. Genetics 190: 295-304.
22. Liu, X. F., T. K. Bera, L. J. Liu, and I. Pastan, 2009 A primate-specific POTE-actin fusion protein plays a role in apoptosis. Apoptosis 14: 1237- 1244.
23. Locke, D. P., L. W. Hillier, W. C. Warren, K. C. Worley, and L. V. Nazareth, 2011 Comparative and demographic analysis of orang-utan genomes. Nature 469: 529-533.
24. Ma, Y., D. Liang, J. Liu, K. Axcrona, G. Kvalheim et al., 2011 Prostate cancer cell lines under hypoxia exhibit greater stem-like properties. PLoS ONE 6: 329170.
25. Ma, Y., D. Liang, J. Liu, K. Axcrona, G. Kvalheim et al., 2012 Synergistic effect of SCF and G-SCF on stem-like properties in prostate cancer cell lines. Tumour Biol. 33: 967-978.
26. Martínez-Arias, R., F. Calafell, E. Mateu, D. Comas, A. Andrés et al., 2001 Sequence variability of a human pseudogene. Genome Res. 11: 1071-1085.
27. McClure, H. M., 1973 Tumors in nonhuman primates: observations during a six year period in the Yerkes primate center colony. Am. J. Phys. Anthropol. 38: 425-429.
28. Mitsui, K., Y. Tokuzawa, H. Itoh, K. Segawa, M. Murakami et al., 2003 The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113: 631-642.
29. Nachman, M. W., and S. L. Crowell, 2000 Estimate of the mutation rate per nucleotide in human. Genetics 156: 297-304.
30. Packer, B. R., M. Yeager, B. Staats, R. Welch, A. Crenshaw et al., 2004 SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res. 32: D528-D532.
31. Puente, X. S., G. Velasco, A. Gutiérrez-Fernández, J. Bertranpetit, M. C. King et al., 2006 Comparative analysis of cancer genes in the human and chimpanzee genomes. BMC Genomics 7: 15.
32. Rohozinski, J., C. L. Edwards, and M. L. Anderson, 2012 Does expression of the retrogene UTP14c in the ovary pre-dispose women to ovarian cancer? Med. Hypotheses 78: 446-449.
33. Scally, A., J. Y. Dutheil, L. W. Hillier, G. E. Jordan, I. Goodhead et al., 2012 Insights into hominid evolution from the gorilla genome sequence. Nature 483: 169-175.
34. Schug, J., 2003 Using TESS to predict transcription factor binding sites in DNA sequence, Unit 2.6 in Current Protocols in Bioinformatics, edited by A. Baxevanis. J. Wiley & Sons, Hoboken, NJ.
35. Snider, L., L. N. Geng, R. J. Lemmers, M. Kyba, C. B. Ware et al., 2010 Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet. 6: e1001181.
36. Tamura, K., D. Peterson, N. Peterson, G. Stecher, M. Nei et al., 2011 MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28: 2731-2739.
37. Tay, Y., J. Zhang, A. M. Thomson, B. Lim, and I. Rigoutsos, 2008 MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455: 1124- 1128.
38. Uchino, K., G. Hirano, M. Hirahashi, T. Isobe, T. Shirakawa et al., 2012 Human Nanog pseudogene8 promotes the proliferation of gastrointestinal cancer cells. Exp. Cell Res. 318: 1799-1807.
39. Wang, H., J. Xing, D. Grover, D. J. Hedges, K. Han et al., 2005 SVA elements: a hominid-specific retroposon family. J. Mol. Biol. 354: 994- 1007.
40. Wang, J., S. Rao, J. Chu, X. Shen, D. N. Levasseur et al., 2006 A protein interaction network for pluripotency of embryonic stem cells. Nature 444: 364-368.
41. Waters, D. J., W. A. Sakr, D. W. Hayden, C. M. Lang, L. McKinney et al., 1998 Workgroup 4: spontaneous prostate carcinoma in dogs and nonhuman primates. Prostate 36: 64-67.
42. Young, J., J. Ménétrey, and B. Goud, 2010 RABC is a retrogene that encodes a centrosomal protein involved in cell cycle progression. J. Mol. Biol. 397: 69-88.
43. Zbinden, M., A. Duquet, A. Lorente-Trigos, S. B. Ngwabyt, I. Borges et al., 2010 NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. EMBO J. 29: 2659- 2674.
44. Zhang, J., X. Wang, M. Li, J. Han, B. Chen et al., 2006 NANOGP8 is a retrogene expressed in cancers. FEBS J. 273: 1723-1730.
45. Zhang, J., X. Wang, B. Chen, Z. Xiao, W. Li et al., 2010 The human pluripotency gene NANOG/NANOGP8 is expressed in gastric cancer and associated with tumor development. Oncol. Lett. 1: 457-463.
46. Zhang, Z., P. M. Harrison, Y. Liu, and M. Gerstein, 2003 Millions of years of evolution preserved: a comprehensive catalog of the processed pseudogenes in the human genome. Genome Res. 13: 2541- 2558.